{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:38:17Z","timestamp":1793122697730,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.diabres.2026.113560","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T14:48:01Z","timestamp":1788706081000},"page":"113560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sex differences in the risk of metformin-associated gastrointestinal adverse events: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"241","author":[{"given":"Alok","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-2299","authenticated-orcid":false,"given":"Antonino","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Biamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilio","family":"Pintaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113560_b0005","unstructured":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process - The Lancet n.d. https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(26)00717-8\/fulltext (accessed June 23, 2026)."},{"key":"10.1016\/j.diabres.2026.113560_b0010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12902-024-01727-w","article-title":"Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies","volume":"24","author":"Nabrdalik","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.diabres.2026.113560_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.16442","article-title":"Metformin use in prediabetes: a review of evidence and a focus on metabolic features among peri-menopausal women","volume":"27","author":"Lim","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113560_b0020","unstructured":"Metformin-Associated Gastrointestinal Intolerance: A Narrative Review of Mechanisms and Clinical Management - Shida Chen, Bingqing Xu, Ming Lu, 2026 n.d. https:\/\/journals.sagepub.com\/doi\/10.1177\/11795514261453485 (accessed June 16, 2026)."},{"key":"10.1016\/j.diabres.2026.113560_b0025","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2337\/dc16-0706","article-title":"Effect of serotonin transporter 5-HTTLPR polymorphism on gastrointestinal intolerance to metformin: a GoDARTS study","volume":"39","author":"Dujic","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113560_b0030","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/db14-1388","article-title":"Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study","volume":"64","author":"Dujic","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113560_b0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10928-015-9436-y","article-title":"Prediction and validation of enzyme and transporter off-targets for metformin","volume":"42","author":"Yee","year":"2015","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.diabres.2026.113560_b0040","first-page":"S181","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142025","volume":"48","author":"Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113560_b0045","article-title":"Metformin: Paradigm of therapeutic pleiotropism (1922-2025)","volume":"165","author":"de Leiva","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.diabres.2026.113560_b0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","article-title":"Women encounter ADRs more often than do men","volume":"64","author":"Zopf","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2026.113560_b0055","doi-asserted-by":"crossref","first-page":"24955","DOI":"10.1038\/srep24955","article-title":"Systematic analysis of adverse event reports for sex differences in adverse drug events","volume":"6","author":"Yu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2026.113560_b0060","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/bcp.13923","article-title":"Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: an explorative observational study","volume":"85","author":"de Vries","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2026.113560_b0065","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2026.113560_b0070","unstructured":"Covidence [Computer program] accessed in 2022. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org."},{"key":"10.1016\/j.diabres.2026.113560_b0075","unstructured":"Higgins J. Cochrane Handbook for Systematic Reviews of Interventions | Cochrane n.d. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook (accessed May 1, 2026)."},{"key":"10.1016\/j.diabres.2026.113560_b0080","unstructured":"Wells GA, Shea B, O\u2019Connell D, et a. Modified Newcastle \u2013Ottawa quality assessment scale for case-control studies Ottawa, Canada: The Ottawa Health Research Institute 2021. http:\/\/www. ohri. ca\/ programs\/ clinical_epidemiology\/ oxford. htm. (accessed May 22, 2026)."},{"key":"10.1016\/j.diabres.2026.113560_b0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40264-020-00913-8","article-title":"Sex differences in adverse drug reactions of metformin: a longitudinal survey study","volume":"43","author":"de Vries","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.diabres.2026.113560_b0090","unstructured":"Borenstein M, Larry. V H, P.T. Higgins J, Rothstein H. A basic introduction to fixed\u2010effect and random\u2010effects models for meta\u2010analysis - Borenstein - 2010 - Research Synthesis Methods - Wiley Online Library 2010. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jrsm.12?msockid=3ea9d0373e2c6685382ec58d3f2a6722 (accessed May 22, 2026)."},{"key":"10.1016\/j.diabres.2026.113560_b0095","unstructured":"Review Manager 5 (RevMan 5) [Computer program]. Version 5.4.1 . Copenhagen : The Cochrane Collaboration; 2020."},{"key":"10.1016\/j.diabres.2026.113560_b0100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2337\/dc18-2182","article-title":"Variation in the plasma membrane monoamine transporter (PMAT) (encoded by SLC29A4) and organic cation transporter 1 (OCT1) (encoded by SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: an IMI direct study","volume":"42","author":"Dawed","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113560_b0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3810\/pgm.2010.03.2128","article-title":"Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes","volume":"122","author":"Florez","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.diabres.2026.113560_b0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113560_b0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"48","author":"Soldin","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diabres.2026.113560_b0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kr\u00f6ll","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.diabres.2026.113560_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200102060-00001","article-title":"Do women have more adverse drug reactions?","volume":"2","author":"Rademaker","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.diabres.2026.113560_b0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40263-021-00794-0","article-title":"Sex differences in the risk of cutaneous adverse drug reactions induced by Antiseizure medications: a systematic review and meta-analysis","volume":"35","author":"Alfares","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.diabres.2026.113560_b0135","doi-asserted-by":"crossref","unstructured":"Joung K-I, Jung G-W, Park H-H, Lee H, Park S-H, Shin J-Y. Gender differences in adverse event reports associated with antidiabetic drugs. Scientific Reports 2020 10:1 2020;10:1\u201310. Doi: 10.1038\/s41598-020-74000-4.","DOI":"10.1038\/s41598-020-74000-4"},{"key":"10.1016\/j.diabres.2026.113560_b0140","unstructured":"Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus - Oktora - 2023 - Pharmacoepidemiology and Drug Safety - Wiley Online Library n.d. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.5672?msockid=3ea9d0373e2c6685382ec58d3f2a6722 (accessed June 15, 2026)."},{"key":"10.1016\/j.diabres.2026.113560_b0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/jcpt.13087","article-title":"Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes","volume":"45","author":"Yuxin","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.diabres.2026.113560_b0150","first-page":"195","article-title":"The effects of metformin on the gut microbiota of patients with type 2 diabetes: a two-center","volume":"10","author":"Nakajima","year":"2020","journal-title":"Quasi-Experi Study Life (Basel)"},{"key":"10.1016\/j.diabres.2026.113560_b0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13300-017-0361-5","article-title":"A class comparison of medication persistence in people with type 2 diabetes: a retrospective observational study","volume":"9","author":"McGovern","year":"2018","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2026.113560_b0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2017.07.120","article-title":"Effects of metformin on endometrial cancer: Systematic review and meta-analysis","volume":"147","author":"Meireles","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.diabres.2026.113560_b0165","doi-asserted-by":"crossref","first-page":"73079","DOI":"10.18632\/oncotarget.20388","article-title":"Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"issue":"41","key":"10.1016\/j.diabres.2026.113560_b0170","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"2018","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113560_b0175","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2152\/jmi.59.166","article-title":"Effectiveness of metformin and lifestyle interventions as an initial treatment in Japanese patients with newly diagnosed type 2 diabetes: a prospective observational study","volume":"59","author":"Sumitani","year":"2012","journal-title":"J Med Invest"},{"key":"10.1016\/j.diabres.2026.113560_b0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002109900152","article-title":"Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors","volume":"361","author":"Cubeddu","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.diabres.2026.113560_b0185","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/pds.5672","article-title":"Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus","volume":"32","author":"Oktora","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.diabres.2026.113560_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001026","article-title":"Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview","volume":"8","author":"Golder","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.diabres.2026.113560_b0195","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.13005\/bpj\/2699","article-title":"Genetic polymorphism in the organic cation transporters 1 (OCT1) Gene and its effect on therapeutic efficacy and gastrointestinal side effects of metformin in patients with type 2 diabetes mellitus in Basrah\/ Southern Iraq","volume":"16","author":"Aladhab","year":"2023","journal-title":"Biomed Pharmacol J"},{"key":"10.1016\/j.diabres.2026.113560_b0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/dme.13040","article-title":"Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes","volume":"33","author":"Dujic","year":"2016","journal-title":"Diabet Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726004808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:25:56Z","timestamp":1793121956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726004808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0168822726004808"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113560","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in the risk of metformin-associated gastrointestinal adverse events: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113560"}}